GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuvation Bio Inc (NYSE:NUVB.WS) » Definitions » Change In Inventory

Nuvation Bio (Nuvation Bio) Change In Inventory : $0.00 Mil (TTM As of Sep. 2021)


View and export this data going back to 2020. Start your Free Trial

What is Nuvation Bio Change In Inventory?

Nuvation Bio's change in inventory for the quarter that ended in Sep. 2021 was $0.00 Mil. It means Nuvation Bio's inventory stayed the same from Jun. 2021 to Sep. 2021 .

Nuvation Bio's change in inventory for the fiscal year that ended in Dec. 2020 was $0.00 Mil. It means Nuvation Bio's inventory stayed the same from . 20 to Dec. 2020 .

Nuvation Bio's Total Inventories for the quarter that ended in Sep. 2021 was $0.00 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.


Nuvation Bio Change In Inventory Historical Data

The historical data trend for Nuvation Bio's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuvation Bio Change In Inventory Chart

Nuvation Bio Annual Data
Trend Dec20 Dec21
Change In Inventory
- -

Nuvation Bio Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
Change In Inventory Get a 7-Day Free Trial - - - - -

Nuvation Bio Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Sep. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nuvation Bio  (NYSE:NUVB.WS) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Nuvation Bio's Days Inventory for the quarter that ended in is calculated as:

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Nuvation Bio's Inventory Turnover for the quarter that ended in Sep. 2021 is calculated as

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Nuvation Bio's Inventory to Revenue for the quarter that ended in Sep. 2021 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nuvation Bio Change In Inventory Related Terms

Thank you for viewing the detailed overview of Nuvation Bio's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.


Nuvation Bio (Nuvation Bio) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
1500 Broadway, Suite 1401, New York, NY, USA, 10036
Nuvation Bio Inc is a biopharmaceutical company. The company is engaged in developing therapeutic candidates for the unmet needs in oncology. The firm operates in pharmaceutical, biotechnology and other related markets that develop small molecules and drug conjugates as treatments for cancer patients.